Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

268 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN

NCT06987864

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Territorial State Budgetary Healthcare Institution "Territorial Clinical Hospital" Barnaul, Russia
  • State Autonomous Healthcare Institution "S.V. Belyaev Kuzbass Regional Clinical Hospital" Kemerovo, Russia
  • Federal State Budgetary Institution of Science "Kirov Research Institute of Hematology and Blood Transfusion of the Federal Medical and Biological Agency" Kirov, Russia
  • Moscow State Budgetary Healthcare Institution "S.P. Botkin Municipal Clinical Hospital of the Moscow Healthcare Department" Moscow, Russia
View Trial Details
Completed

Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT02534909

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Brno-Bohunice, Czech Republic, Czechia
  • Novartis Investigative Site Fukushima, Japan
  • Novartis Investigative Site Isehara, Kanagawa, Japan
  • Novartis Investigative Site Suita, Osaka, Japan
View Trial Details
Completed

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)

NCT04469465

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Weston, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Kalamazoo, Michigan, United States
View all 62 locations
View Trial Details
Completed

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576

NCT03588026

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Almaty City Hospital No.7 Almaty, Microdistrict Kalkaman, Kazakhstan
  • Vilnius University Hospital Santaros Klinikos , Santariškių St. 2, LT-08661, Vilnius, Lithuania
  • University of Kelaniya, Faculty of Medicine, Thalagolla Road Colombo, Sri Lanka
View Trial Details
Completed

Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy

NCT04811716

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Prince of Wales Hospital Hong Kong, New Territories
  • D l Pesti Centrumk rh z Orsz gos Hematol giai s Infektol giai Int zet Budapest, Nagyvárad Tér 1, Hungary
  • Hospital Miri Miri, Sarawak, Malaysia
  • Hospital Sibu Sibu, Sarawak, Malaysia
View all 13 locations
View Trial Details
Completed

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

NCT03056040

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Detroit, Michigan, United States
View all 51 locations
View Trial Details

Related conditions